ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,995Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 2456

$949K Total Retail Price of All Prescriptions

Rank: 40 out of 2456

515 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 515 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 515 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 13,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 755 687 1 2
FUROSEMIDE 556 448 2 8
LISINOPRIL 501 438 3 1
OMEPRAZOLE 463 374 4 3
WARFARIN SODIUM 462 428 5 9
LEVOTHYROXINE SODIUM 426 377 6 4
METOPROLOL SUCCINATE 330 319 7 13
CITALOPRAM HBR 284 248 8 14
ATORVASTATIN CALCIUM 275 240 9 12
AMLODIPINE BESYLATE 260 247 10 5
DONEPEZIL HCL 255 244 11 23
METOPROLOL TARTRATE 255 234 11 10
MIRTAZAPINE 232 206 13 29
GABAPENTIN 223 154 14 16
TRAZODONE HCL 216 204 15 17
NAMENDA 209 209 16 42
ALLOPURINOL 207 190 17 27
METFORMIN HCL 206 178 18 11
MELOXICAM 201 175 19 121
ALENDRONATE SODIUM 197 172 20 19
ZOLPIDEM TARTRATE 178 146 21 28
HYDROCODONE-ACETAMINOPHEN 158 114 S3 22 20
HYDROCHLOROTHIAZIDE 152 148 23 7
CLOPIDOGREL 148 125 24 55
TAMSULOSIN HCL 139 128 25 32
SERTRALINE HCL 137 137 26 21
PRAVASTATIN SODIUM 127 109 27 15
AZITHROMYCIN 127 112 27 60
PANTOPRAZOLE SODIUM 125 118 29 37
ATENOLOL 123 122 30 6
LOSARTAN POTASSIUM 121 116 31 18
GLIPIZIDE 119 117 32 46
ADVAIR DISKUS 115 90 33 36
DIVALPROEX SODIUM 114 94 34 51
QUETIAPINE FUMARATE 106 87 35 47
LEVETIRACETAM 100 81 36 90
LIDODERM 100 100 36 58
AMOX TR-POTASSIUM CLAVULANATE 96 86 38 194
FENOFIBRATE 94 82 39 68
PLAVIX 92 76 40 79
CARVEDILOL 91 75 41 54
GLIPIZIDE ER 91 69 41 89
NIFEDIPINE ER 88 88 43 61
LANTUS 87 79 44 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 69 45 41
TRAMADOL HCL 86 73 45 24
DIOVAN 85 85 47 26
SPIRIVA 77 70 48 43
POTASSIUM CHLORIDE 75 48 49 33
NITROFURANTOIN 74 69 50 224
EXELON 69 69 51 161
VENLAFAXINE HCL ER 67 67 52 92
ISOSORBIDE MONONITRATE ER 67 67 52 48
MECLIZINE HCL 66 66 54 107
CRESTOR 66 50 54 25
PREDNISONE 66 60 54 39
DIOVAN HCT 63 63 57 139
FLUTICASONE PROPIONATE 63 46 57 30
PROAIR HFA 60 45 59 22
DIGOXIN 60 59 59 49
LORAZEPAM 58 53 61 67
METHENAMINE HIPPURATE 57 57 62 237
OLANZAPINE 57 56 62 57
FAMOTIDINE 54 54 64 84
LEVOFLOXACIN 50 44 65 103
DILTIAZEM 24HR CD 50 50 65 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.